Happenings Archive

What's Happening Now is a quick, thoughtful, real-time briefing regarding material events in the stem cell industry...definitely not the usual stream of insignificant press releases. The most current Happenings are boxed on the left-hand side of most pages on this site. Feel free to use this page to explore the archive of all past Happening items, and subscribe to the RSS feed to stay on top of the events that move the market and the industry.

COMPANY:

SCSI Initiates Coverage of bluebird bio
Aug 11, 2013
Following the recent completion of its IPO, stem cell gene therapy company bluebird bio joins the SCSI as the component with the index's highest market cap, $648M versus #2 Osiris Therapeutics' $345M. bluebird's two clinical trials are now included in our Clinical Trials Monitor.
< Previous Page  |  Next Page >